Prenatal latex sensitization in patients with spina bifida: a pilot study
Standard
Prenatal latex sensitization in patients with spina bifida: a pilot study. / Boettcher, Michael; Göttler, Susanne; Eschenburg, Georg; Kracht, Thorben; Kunkel, Philip; Von der Wense, Axel; Reinshagen, Konrad.
in: J NEUROSURG-PEDIATR, Jahrgang 13, Nr. 3, 01.03.2014, S. 291-4.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Prenatal latex sensitization in patients with spina bifida: a pilot study
AU - Boettcher, Michael
AU - Göttler, Susanne
AU - Eschenburg, Georg
AU - Kracht, Thorben
AU - Kunkel, Philip
AU - Von der Wense, Axel
AU - Reinshagen, Konrad
PY - 2014/3/1
Y1 - 2014/3/1
N2 - OBJECT: Patients with spina bifida are particularly vulnerable to developing immunoglobulin E (IgE)-mediated latex sensitization. Even though many risk factors leading to latex allergy in these patients have been described, it is still unclear whether the increased prevalence of latex sensitization is disease associated or due to the procedures used to treat spina bifida. The aim of this study was to assess prenatal latex sensitization in patients with spina bifida by examining IgE levels in umbilical cord blood.METHODS: Patients with spina bifida and matched healthy infants were recruited from the University Medical Center Hamburg-Eppendorf and Children's Hospital Altona. Latex-specific and total IgE were assessed in umbilical cord blood using ImmunoCAP testing to evaluate the degree of prenatal latex sensitization.RESULTS: Twenty-two subjects, 10 with spina bifida and 12 healthy individuals, were included. Subjects were selected after matching for sex, gestational age, weight, parental allergy profile, number of prenatal examinations, and utilization of latex tools during pregnancy (propensity score estimates, p = 0.36). In patients with spina bifida, latex-specific and total IgE levels were significantly higher than those in healthy individuals (p = 0.001). After normalization to total IgE, latex-specific IgE levels were higher, yet not significantly increased (p = 0.085).CONCLUSIONS: Perinatally, there is a significant augmentation of total and latex-specific IgE in patients with spina bifida. After correcting for total IgE, latex-specific IgE was increased, yet not significantly higher than in matched, healthy controls. This pilot study gives novel insights in the immunological reactions related to spina bifida. The increased latex-specific IgE levels could possibly be associated with the occurrence of a latex allergy in the future.
AB - OBJECT: Patients with spina bifida are particularly vulnerable to developing immunoglobulin E (IgE)-mediated latex sensitization. Even though many risk factors leading to latex allergy in these patients have been described, it is still unclear whether the increased prevalence of latex sensitization is disease associated or due to the procedures used to treat spina bifida. The aim of this study was to assess prenatal latex sensitization in patients with spina bifida by examining IgE levels in umbilical cord blood.METHODS: Patients with spina bifida and matched healthy infants were recruited from the University Medical Center Hamburg-Eppendorf and Children's Hospital Altona. Latex-specific and total IgE were assessed in umbilical cord blood using ImmunoCAP testing to evaluate the degree of prenatal latex sensitization.RESULTS: Twenty-two subjects, 10 with spina bifida and 12 healthy individuals, were included. Subjects were selected after matching for sex, gestational age, weight, parental allergy profile, number of prenatal examinations, and utilization of latex tools during pregnancy (propensity score estimates, p = 0.36). In patients with spina bifida, latex-specific and total IgE levels were significantly higher than those in healthy individuals (p = 0.001). After normalization to total IgE, latex-specific IgE levels were higher, yet not significantly increased (p = 0.085).CONCLUSIONS: Perinatally, there is a significant augmentation of total and latex-specific IgE in patients with spina bifida. After correcting for total IgE, latex-specific IgE was increased, yet not significantly higher than in matched, healthy controls. This pilot study gives novel insights in the immunological reactions related to spina bifida. The increased latex-specific IgE levels could possibly be associated with the occurrence of a latex allergy in the future.
KW - Case-Control Studies
KW - Child
KW - Child, Preschool
KW - Female
KW - Fetal Blood
KW - Humans
KW - Immunoglobulin E
KW - Infant
KW - Infant, Newborn
KW - Latex
KW - Latex Hypersensitivity
KW - Male
KW - Pilot Projects
KW - Pregnancy
KW - Prenatal Exposure Delayed Effects
KW - Risk Factors
KW - Spinal Dysraphism
U2 - 10.3171/2013.12.PEDS13402
DO - 10.3171/2013.12.PEDS13402
M3 - SCORING: Journal article
C2 - 24404967
VL - 13
SP - 291
EP - 294
JO - J NEUROSURG-PEDIATR
JF - J NEUROSURG-PEDIATR
SN - 1933-0707
IS - 3
ER -